utR Biotech emerge excel exploit evolve
utR Biotech aims to improve insulin-dependent diabetes outcomes by adding peptides to insulin formulations. The company develops, optimizes, purifies, and scales recombinant proteins and a lyophilized insulin-peptide formulation to extend shelf-life and accessibility. It leverages cell culture, protein purification, and product development as core technologies, and collaborates with an AI partner to identify biomarkers and clinical indications. The research targets reducing cardiovascular disease, neuropathy, Alzheimer's, and cancer risks associated with diabetes, with IP expected around data from grants. The focus is on affordable therapeutics for global health, with a business model spanning SaaS, licensing, and services.
utR Biotech emerge excel exploit evolve
utR Biotech aims to improve insulin-dependent diabetes outcomes by adding peptides to insulin formulations. The company develops, optimizes, purifies, and scales recombinant proteins and a lyophilized insulin-peptide formulation to extend shelf-life and accessibility. It leverages cell culture, protein purification, and product development as core technologies, and collaborates with an AI partner to identify biomarkers and clinical indications. The research targets reducing cardiovascular disease, neuropathy, Alzheimer's, and cancer risks associated with diabetes, with IP expected around data from grants. The focus is on affordable therapeutics for global health, with a business model spanning SaaS, licensing, and services.